Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients

NCT04135287 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

315

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: GLP-1 receptor agonist

Sponsor

Dasman Diabetes Institute